{"id":"https://openalex.org/W4362552859","doi":"https://doi.org/10.1158/2326-6066.22538126","title":"Supplementary Figures S1-S5 from STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients","display_name":"Supplementary Figures S1-S5 from STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362552859","doi":"https://doi.org/10.1158/2326-6066.22538126"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.22538126","doi":"https://doi.org/10.1158/2326-6066.22538126","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22538126","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.22538126","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017163410","display_name":"Raghvendra Mohan Srivastava","orcid":"https://orcid.org/0000-0001-6545-3957","observed_orcids":["https://orcid.org/0000-0001-6545-3957"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raghvendra M. Srivastava","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904496","display_name":"Sumita Trivedi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sumita Trivedi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071719413","display_name":"Fernando Concha\u2010Benavente","orcid":"https://orcid.org/0000-0002-3079-1996","observed_orcids":["https://orcid.org/0000-0002-3079-1996"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fernando Concha-Benavente","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101198472","display_name":"Hyun-Bae Jie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jie Hyun-bae","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100403148","display_name":"Lin Wang","orcid":"https://orcid.org/0000-0002-1787-5298","observed_orcids":["https://orcid.org/0000-0002-1787-5298"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lin Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056955251","display_name":"Raja R. Seethala","orcid":"https://orcid.org/0000-0003-3617-075X","observed_orcids":["https://orcid.org/0000-0003-3617-075X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raja R. Seethala","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009079779","display_name":"Barton F. Branstetter","orcid":"https://orcid.org/0000-0002-8502-6909","observed_orcids":["https://orcid.org/0000-0002-8502-6909"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barton F. Branstetter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028669896","display_name":"Soldano Ferrone","orcid":"https://orcid.org/0000-0003-2900-8834","observed_orcids":["https://orcid.org/0000-0003-2900-8834"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Soldano Ferrone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5086074491","display_name":"Robert Louis Ferris","orcid":"https://orcid.org/0000-0001-6605-2071","observed_orcids":["https://orcid.org/0000-0001-6605-2071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert L. Ferris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4982999861240387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4982999861240387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.1808999925851822,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.1316000074148178,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/stat1","display_name":"STAT1","score":0.9470000267028809},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/anti-egfr-monoclonal-antibody","display_name":"anti-EGFR monoclonal antibody","score":0.9179999828338623},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8600000143051147},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.847000002861023},{"id":"https://openalex.org/keywords/shp2","display_name":"SHP2","score":0.8510000109672546},{"id":"https://openalex.org/keywords/tap1","display_name":"TAP1","score":0.8930000066757202},{"id":"https://openalex.org/keywords/lmp2","display_name":"LMP2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.3160000145435333}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9633985757827759},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4679469168186188},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.4672517776489258},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4515230059623718},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38000866770744324},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3487662374973297},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3035922944545746},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.26853322982788086},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1901053786277771},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15773773193359375}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2326-6066.22538126","doi":"https://doi.org/10.1158/2326-6066.22538126","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22538126","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/2326-6066.22538126.v1","doi":"https://doi.org/10.1158/2326-6066.22538126.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22538126.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.22538126","doi":"https://doi.org/10.1158/2326-6066.22538126","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22538126","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7099669809","https://openalex.org/W4362546036","https://openalex.org/W2203636072","https://openalex.org/W2064991312","https://openalex.org/W2156343417","https://openalex.org/W2764025270","https://openalex.org/W2033326553","https://openalex.org/W4377245421","https://openalex.org/W2069827107","https://openalex.org/W3035383735"],"abstract_inverted_index":{"Supplementary":[0,22,52,94,128],"figure":[1,23,53,95,129],"S1.":[2],"JHU-029":[3,25,55,97],"HNC":[4],"cells":[5,59],"were":[6,10,26,60,90,98,124],"left":[7],"untreated":[8],"or":[9],"treated":[11,27,61,99],"for":[12],"48h":[13],"with":[14,29,50,62,101,126],"the":[15],"EGFR":[16,65,72,79],"inhibitor":[17],"mAb":[18],"cetuximab":[19,30,36,102,108],"(10":[20,31,34,39,103,106,111],"mg/ml).":[21],"S2.":[24],"(48h),":[28,100],"mg/ml),":[32,104],"IFNg":[33,38,105,110],"U/ml),":[35,107],"plus":[37,69,74,109],"mg/ml,":[40,112],"10":[41,113],"U/ml)":[42,114],"and":[43,57,71,76,81,83,88,115,121],"transcript":[44,116],"level":[45,117],"of":[46,78,118,132],"SHP2":[47],"was":[48],"analyzed":[49,125],"qPCR.":[51,127],"S3.":[54],"(A-B),":[56],"PCI-13(C-D),":[58],"control":[63,67],"siRNA,":[64,66],"siRNA":[68,73],"cetuximab,":[70,75],"levels":[77],"(A":[80],"C),":[82],"HLA":[84],"class":[85],"I":[86],"(B":[87],"D),":[89],"determined":[91],"by":[92],"FACS.":[93],"S4.":[96],"TAP1":[119],"(A),":[120],"LMP2":[122],"(B),":[123],"S5.":[130],"Characterization":[131],"HLA-A2:MAGE-3":[133],"complex":[134],"mAb.":[135]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}